Skip to main content
Top
Published in: International Orthopaedics 11/2013

01-11-2013 | Original Paper

Repair of segmental long-bone defects by stem cell concentrate augmented scaffolds: a clinical and positron emission tomography - computed tomography analysis

Authors: Maximilian Petri, Ali Namazian, Florian Wilke, Max Ettinger, Timo Stübig, Stephan Brand, Frank Bengel, Christian Krettek, Georg Berding, Michael Jagodzinski

Published in: International Orthopaedics | Issue 11/2013

Login to get access

Abstract

Purpose

Treating segmental long-bone defects remains a major challenge. For defects >3 cm, segmental transport represents the gold standard, even though the method is time consuming and afflicted with several complications. The aim of this study was to evaluate healing of such defects after grafting an osteogenic scaffold previously seeded with stem cell concentrate.

Methods

We evaluated five patients with segmental long-bone defects (3–14 cm) treated with bone marrow aspirate concentrates (BMAC) seeded onto a bovine xenogenous scaffold. The healing process was monitored by X-rays and positron emission tomography–computed tomography (PET-CT) three months after surgery.

Results

Centrifugation led to a concentration of leukocytes by factor 8.1 ± 7.5. Full weight bearing was achieved 11.3 ± 5.0 weeks after surgery. PET analysis showed an increased influx of fluoride by factor 8.3 ± 6.4 compared with the contralateral side (p < 0.01). Bone density in the cortical area was 75 ± 16 % of the contralateral side (p < 0.03). The patient with the largest defect sustained an implant failure in the distal femur and finally accomplished therapy by segmental transport. He also had the lowest uptake of fluoride of the patient collective (2.2-fold increase).

Conclusion

Stem cell concentrates can be an alternative to segmental bone transport. Further studies are needed to compare this method with autologous bone grafting and segmental transport.
Literature
1.
go back to reference Jager M, Herten M, Fochtmann U et al (2011) Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects. J Orthop Res 29(2):173–180PubMedCrossRef Jager M, Herten M, Fochtmann U et al (2011) Bridging the gap: bone marrow aspiration concentrate reduces autologous bone grafting in osseous defects. J Orthop Res 29(2):173–180PubMedCrossRef
2.
go back to reference Al-Zube L, Breitbart EA, O’Connor JP et al (2009) Recombinant human platelet-derived growth factor BB (rhPDGF-BB) and beta-tricalcium phosphate/collagen matrix enhance fracture healing in a diabetic rat model. J Orthop Res 27(8):1074–1081PubMedCrossRef Al-Zube L, Breitbart EA, O’Connor JP et al (2009) Recombinant human platelet-derived growth factor BB (rhPDGF-BB) and beta-tricalcium phosphate/collagen matrix enhance fracture healing in a diabetic rat model. J Orthop Res 27(8):1074–1081PubMedCrossRef
3.
go back to reference Bessa PC, Casal M, Reis RL (2008) Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2(2–3):81–96PubMedCrossRef Bessa PC, Casal M, Reis RL (2008) Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2(2–3):81–96PubMedCrossRef
4.
go back to reference Bessa PC, Casal M, Reis RL (2008) Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2(1):1–13PubMedCrossRef Bessa PC, Casal M, Reis RL (2008) Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2(1):1–13PubMedCrossRef
5.
go back to reference Ghodadra N, Singh K (2008) Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures. Biogeosciences 2(3):345–354 Ghodadra N, Singh K (2008) Recombinant human bone morphogenetic protein-2 in the treatment of bone fractures. Biogeosciences 2(3):345–354
6.
go back to reference Giannoudis PV, Tzioupis C (2005) Clinical applications of BMP-7: the UK perspective. Injury 36(Suppl 3):S47–S50PubMedCrossRef Giannoudis PV, Tzioupis C (2005) Clinical applications of BMP-7: the UK perspective. Injury 36(Suppl 3):S47–S50PubMedCrossRef
7.
go back to reference Dimitriou R, Dahabreh Z, Katsoulis E et al (2005) Application of recombinant BMP-7 on persistent upper and lower limb non-unions. Injury 36(Suppl 4):S51–S59PubMedCrossRef Dimitriou R, Dahabreh Z, Katsoulis E et al (2005) Application of recombinant BMP-7 on persistent upper and lower limb non-unions. Injury 36(Suppl 4):S51–S59PubMedCrossRef
8.
go back to reference Graham S, Leonidou A, Lester M et al (2009) Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing. Expert Opin Investig Drugs 18(11):1633–1654PubMedCrossRef Graham S, Leonidou A, Lester M et al (2009) Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing. Expert Opin Investig Drugs 18(11):1633–1654PubMedCrossRef
9.
go back to reference Hollinger JO, Hart CE, Hirsch SN et al (2008) Recombinant human platelet-derived growth factor: biology and clinical applications. J Bone Joint Surg Am 90(Suppl 1):48–54PubMedCrossRef Hollinger JO, Hart CE, Hirsch SN et al (2008) Recombinant human platelet-derived growth factor: biology and clinical applications. J Bone Joint Surg Am 90(Suppl 1):48–54PubMedCrossRef
10.
go back to reference Hollinger JO, Onikepe AO, MacKrell J et al (2008) Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-BB and an injectable beta-tricalcium phosphate/collagen matrix. J Orthop Res 26(1):83–90PubMedCrossRef Hollinger JO, Onikepe AO, MacKrell J et al (2008) Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-BB and an injectable beta-tricalcium phosphate/collagen matrix. J Orthop Res 26(1):83–90PubMedCrossRef
11.
go back to reference Kasten P, Vogel J, Geiger F et al (2008) The effect of platelet-rich plasma on healing in critical-size long-bone defects. Biomaterials 29(29):3983–3992PubMedCrossRef Kasten P, Vogel J, Geiger F et al (2008) The effect of platelet-rich plasma on healing in critical-size long-bone defects. Biomaterials 29(29):3983–3992PubMedCrossRef
12.
go back to reference Lissenberg-Thunnissen SN, de Gorter DJ, Sier CF, Schipper IB (2011) Use and efficacy of bone morphogenetic proteins in fracture healing. Int Orthop 35(9):1271–1280PubMedCrossRef Lissenberg-Thunnissen SN, de Gorter DJ, Sier CF, Schipper IB (2011) Use and efficacy of bone morphogenetic proteins in fracture healing. Int Orthop 35(9):1271–1280PubMedCrossRef
13.
go back to reference Bishop GB, Einhorn TA (2007) Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 31(6):721–727PubMedCrossRef Bishop GB, Einhorn TA (2007) Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop 31(6):721–727PubMedCrossRef
14.
go back to reference Hendrich C, Franz E, Waertel G et al (2009) Safety of autologous bone marrow aspiration concentrate transplantation: initial experiences in 101 patients. Orthop Rev (Pavia) 1(2):e32CrossRef Hendrich C, Franz E, Waertel G et al (2009) Safety of autologous bone marrow aspiration concentrate transplantation: initial experiences in 101 patients. Orthop Rev (Pavia) 1(2):e32CrossRef
15.
go back to reference Jager M, Jelinek EM, Wess KM et al (2009) Bone marrow concentrate: a novel strategy for bone defect treatment. Curr Stem Cell Res Ther 4(1):34–43PubMedCrossRef Jager M, Jelinek EM, Wess KM et al (2009) Bone marrow concentrate: a novel strategy for bone defect treatment. Curr Stem Cell Res Ther 4(1):34–43PubMedCrossRef
16.
go back to reference Gessmann J, Köller M, Godry H et al (2012) Regenerate augmentation with bone marrow concentrate after traumatic bone loss. Orthop Rev (Pavia) 4(1):e14CrossRef Gessmann J, Köller M, Godry H et al (2012) Regenerate augmentation with bone marrow concentrate after traumatic bone loss. Orthop Rev (Pavia) 4(1):e14CrossRef
17.
go back to reference Schliephake H, Berding G, Knapp WH, Sewilam S (1999) Monitoring of graft perfusion and osteoblast activity in revascularised fibula segments using [18F]-positron emission tomography. Int J Oral Maxillofac Surg 28(5):349–355PubMedCrossRef Schliephake H, Berding G, Knapp WH, Sewilam S (1999) Monitoring of graft perfusion and osteoblast activity in revascularised fibula segments using [18F]-positron emission tomography. Int J Oral Maxillofac Surg 28(5):349–355PubMedCrossRef
18.
go back to reference Guda T, Walker JA, Singleton BM et al (2013) Guided bone regeneration in long-bone defects with a structural hydroxyapatite graft and collagen membrane. Tissue Eng Part A 19(17–18):1879–1888PubMedCrossRef Guda T, Walker JA, Singleton BM et al (2013) Guided bone regeneration in long-bone defects with a structural hydroxyapatite graft and collagen membrane. Tissue Eng Part A 19(17–18):1879–1888PubMedCrossRef
19.
go back to reference Reichert JC, Cipitria A, Epari DR et al (2012) A tissue engineering solution for segmental defect regeneration in load-bearing long bones. Sci Transl Med 4(141):141ra93PubMedCrossRef Reichert JC, Cipitria A, Epari DR et al (2012) A tissue engineering solution for segmental defect regeneration in load-bearing long bones. Sci Transl Med 4(141):141ra93PubMedCrossRef
20.
go back to reference Goshima K, Nakase J, Xu Q et al (2012) Repair of segmental bone defects in rabbit tibia promoted by a complex of beta-tricalcium phosphate and hepatocyte growth factor. J Orthop Sci 17(5):639–648PubMedCrossRef Goshima K, Nakase J, Xu Q et al (2012) Repair of segmental bone defects in rabbit tibia promoted by a complex of beta-tricalcium phosphate and hepatocyte growth factor. J Orthop Sci 17(5):639–648PubMedCrossRef
21.
go back to reference Sauerbier S, Rickert D, Gutwald R et al (2011) Bone marrow concentrate and bovine bone mineral for sinus floor augmentation: a controlled, randomized, single-blinded clinical and histological trial-per-protocol analysis. Tissue Eng Part A 17(17–18):2187–2197PubMedCrossRef Sauerbier S, Rickert D, Gutwald R et al (2011) Bone marrow concentrate and bovine bone mineral for sinus floor augmentation: a controlled, randomized, single-blinded clinical and histological trial-per-protocol analysis. Tissue Eng Part A 17(17–18):2187–2197PubMedCrossRef
22.
go back to reference Rickert D, Sauerbier S, Nagursky H et al (2011) Maxillary sinus floor elevation with bovine bone mineral combined with either autogenous bone or autogenous stem cells: a prospective randomized clinical trial. Clin Oral Implants Res 22(3):251–258PubMedCrossRef Rickert D, Sauerbier S, Nagursky H et al (2011) Maxillary sinus floor elevation with bovine bone mineral combined with either autogenous bone or autogenous stem cells: a prospective randomized clinical trial. Clin Oral Implants Res 22(3):251–258PubMedCrossRef
23.
go back to reference Zhong W, Sumita Y, Ohba S et al (2012) In vivo comparison of the bone regeneration capability of human bone marrow concentrates vs. platelet-rich plasma. PLoS One 7(7):e40833PubMedCrossRef Zhong W, Sumita Y, Ohba S et al (2012) In vivo comparison of the bone regeneration capability of human bone marrow concentrates vs. platelet-rich plasma. PLoS One 7(7):e40833PubMedCrossRef
24.
go back to reference Cao L, Liu G, Gan Y et al (2012) The use of autologous enriched bone marrow MSCs to enhance osteoporotic bone defect repair in long-term estrogen deficient goats. Biomaterials 33(20):5076–5084PubMedCrossRef Cao L, Liu G, Gan Y et al (2012) The use of autologous enriched bone marrow MSCs to enhance osteoporotic bone defect repair in long-term estrogen deficient goats. Biomaterials 33(20):5076–5084PubMedCrossRef
25.
go back to reference Buttaro MA, Constantini J, Comba F, Piccaluga F (2012) The use of femoral struts and impacted cancellous bone allograft in patients with severe femoral bone loss who undergo revision total hip replacement: a three- to nine-year follow-up. J Bone Joint Surg Br 94(2):167–172PubMed Buttaro MA, Constantini J, Comba F, Piccaluga F (2012) The use of femoral struts and impacted cancellous bone allograft in patients with severe femoral bone loss who undergo revision total hip replacement: a three- to nine-year follow-up. J Bone Joint Surg Br 94(2):167–172PubMed
Metadata
Title
Repair of segmental long-bone defects by stem cell concentrate augmented scaffolds: a clinical and positron emission tomography - computed tomography analysis
Authors
Maximilian Petri
Ali Namazian
Florian Wilke
Max Ettinger
Timo Stübig
Stephan Brand
Frank Bengel
Christian Krettek
Georg Berding
Michael Jagodzinski
Publication date
01-11-2013
Publisher
Springer Berlin Heidelberg
Published in
International Orthopaedics / Issue 11/2013
Print ISSN: 0341-2695
Electronic ISSN: 1432-5195
DOI
https://doi.org/10.1007/s00264-013-2087-y

Other articles of this Issue 11/2013

International Orthopaedics 11/2013 Go to the issue